Patent Assignment
Reel/Frame 027533/0702
Corrective Assignment to Correct the Spelling of Assignee from "Origent Therapeutics, Inc." to "Origen Therapeutics, Inc." Previously Recorded on Reel 016261 Frame 0190. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.
Recorded: 2012-01-13
Pages: 6
Assignee
ORIGEN THERAPEUTICS, INC.
1450 ROLLINS ROAD, BURLINGAME, CALIFORNIA, 94010-2307
Covered Property
(1)
Long-term culture of avian primordial germ cells (PGCs)
Application:
11/049,229 →
Publication:
US 2006/0174362
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 3, 2012
From: ORIGEN THERAPEUTICS, INC.
To: SYMPHOGEN A/S
Reel/Frame 027473/0627 →
Assignment of Assignor's Interest
Jan 23, 2013
From: SYMPHOGEN A/S
To: ORIGEN THERAPEUTICS, INC.
Reel/Frame 029677/0063 →
Assignment of Assignor's Interest
Jan 23, 2013
From: ORIGEN THERAPEUTICS, INC.
To: INSOLVENCY SERVICES GROUP (ISG)
Reel/Frame 029677/0122 →
Assignment of Assignor's Interest
Jan 23, 2013
From: INSOLVENCY SERVICES GROUP (ISG)
To: SYNAGEVA BIOPHARMA CORP.
Reel/Frame 029677/0139 →
Merger and Change of Name
Jun 16, 2016
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 038932/0583 →
Assignment of Assignor's Interest
Jan 11, 2017
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 040950/0266 →